The FDA restricted the import of certain banana ketchup and other Filipino condiments because some of their ingredients exceed permissible levels. The ingredients of concern include potassium ...

Brenner, who has worked in the FDA’s Center for Devices and Radiological Health, will lead the agency until a permanent ...

Since the announcement that president-elect Donald Trump would nominate Robert F. Kennedy Jr. (RFK Jr.) as the secretary of the U.S. Department ...

With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...

Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...

The decision by Trump’s team to tap Heather Flick as HHS chief of staff signals an effort to keep closer watch on the ...

In its final days, the Biden administration's FDA is expected to propose a limit on the amount of nicotine in cigarettes.

J&J agreed to buy Intra-Cellular Therapies in a deal worth $14.6 billion, another sign of reentry into neuroscience by large ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

Israeli Ambassador to the United Nations Danny Danon, spoke to Arutz Sheva-Israel National News during his visit to Israel about his hopes for the incoming US administration. “We are waiting for ...

Endpoints Weekly reports on iECURE's gene therapy success for OTC deficiency, FDA CDER director Patrizia Cavazzoni's departure, and Verdiva Bio's $411M launch with Sciwind assets.

Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.